EquityZen Growth Technology Fund LLC - Series 253
Raised
$566K
Investors
21
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 253 is a Delaware pooled investment vehicle filed by EquityZen Advisors LLC on 2018-06-04, raising $566K from 21 investors under Rule 506(b) and 3(c)(1) exemptions. The fund is part of the EquityZen platform, which operates a large family of pre-IPO investment vehicles with over 1,800 related EDGAR entities. Minimum investment is $10K.
This pre-IPO pooled fund uses the standard 506(b) private placement exemption paired with 3(c)(1) Investment Company Act relief, typical for smaller venture-stage SPVs. The $10K minimum investment and $566K total raise reflect EquityZen's retail-accessible model, substantially lower than institutional pre-IPO funds that often require $100K+ minimums.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
